PETV
PetVivo Holdings, Inc. · Healthcare
Insiders bought $860K of PetVivo Holdings, Inc. in the last 12 months
1 insider bought on 6 days.
PETV over the last year
Largest buyers, last 12 months
PETV after insider buys
3 months after each buy, from the first price a copier could get.
4 buys since 2021 with 3 months of prices.
Every filing
11 insider filings since 2021, newest first
A.L. Sarroff Fund, LLC · 10% owner
A.L. Sarroff Fund, LLC · 10% owner
A.L. Sarroff Fund, LLC · 10% owner
A.L. Sarroff Fund, LLC · 10% owner
A.L. Sarroff Fund, LLC · 10% owner
A.L. Sarroff Fund, LLC · 10% owner
John Lai · CEO and President
James Rudolph Martin · Director
Scott Mitchell Johnson · Director
Robert J. Folkes · CFO
James Rudolph Martin · Director
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.